History of Computers in Pharmaceutical Research and Development: A Narrative

Computer Applications in Pharmaceutical Research and Development

Volumn , Issue , 2006, Pages 1-50

  Boyd, Donald B ^a   Marsh, Max M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Computer based drug discovery; Interdisciplinary team effort in computational chemistry; Pharmaceutical R D effort

Indexed keywords

EID: 57849132109     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470037237.ch1     Document Type: Chapter

References (136)

1. Fischer E. Einfluß der Konfiguration auf die Wirkung der Enzymen. Ber Dtsch Chem Ges 1894;27:2985-93.
2. Silverman RB. The organic chemistry of drug design and drug action. San Diego: Academic Press, 1992.
3. Messiah A. Quantum mechanics, Vol. I. (Translated from the French by Temmer GM). New York: Wiley, 1966.
4. Pullman B, Pullman A. Quantum biochemistry. New York: Interscience Publishers, Wiley, 1963.
5. Crum Brown A, Frazer TR. On the connection between chemical constitution and physiological action. Part I. On the physiological action of the salts of the ammonium bases, derived from strychnia, brucia, thebaia, codeia, morphia, and nicoti. Trans R Soc Edinburgh 1869;25:151-203.
6. Crum Brown A, Frazer TR. On the connection between chemical constitution and physiological action. Part II. On the physiological action of the ammonium bases derived from atropia and conia. Trans R Soc Edinburgh 1869;25:693-739.
7. Bruice TC, Kharasch N, Winzler RJ. A correlation of thyroxine-like activity and chemical structure. Arch Biochem Biophys 1956;62:305-17.
8. Zahradnik R. Correlation of the biological activity of organic compounds by means of the linear free energy relations. Experimentia 1962;18:534-6.
9. Hansch C, Fujita T. ρ-σ-π Analysis; method for the correlation of biological activity and chemical structure. J Am Chem Soc 1964;86:1616-26.
10. Free SM Jr, Wilson JW. A mathematical contribution to structure-activity studies. J Med Chem 1964;7:395-9.
11. Bolcer JD, Hermann RB. The development of computational chemistry in the United States. In: Lipkowitz KB, Boyd DB, editors. Reviews in computational chemistry, Vol. 5. New York: VCH, 1994. p. 1-63.
12. Marsh MM. Spectropolarimetric studies on proteins. Bovine plasma albumin and insulin. J Am Chem Soc 1962;84:1896-900.
13. Moffitt W. Optical rotatory dispersion of helical polymers. J Chem Phys 1956;25:467-78.
14. Allinger N, Allinger J. Structures of organic molecules. Englewood Cliffs, NJ:Prentice-Hall, 1965.
15. Dayhoff MO. Computer search for active-site configurations. J Am Chem Soc 1964;86:2295-7.
16. Lipkowitz KB, Boyd DB, editors. Books Published on the Topics of Computational Chemistry. In: Reviews in Computational Chemistry, Vol. 17. New York:Wiley-VCH, 2001. p. 255-357.
17. Lipkowitz KB, Boyd DB, editors. A tribute to the halcyon days of QCPE. In:Reviews in Computational Chemistry, Vol. 15. New York: Wiley-VCH, 2000. p. v-xi.
18. Johnson CK. Drawing crystal structures by computer. Crystallographic Computing, Proceedings of the International Summer School held 1969, 1970. p. 227-30.
19. Sutton LE, Jenkin DG, Mitchell AD, Cross LC, editors. Tables of interatomic distances and configuration in molecules and ions, Special Publ No. 11. London:The Chemical Society, 1958.
20. Koltun WL. Precision space-filling atomic models. Biopolymers 1965;3:665-79.
21. Boyd DB. Space-filling molecular models of four-membered rings. Threedimensional aspects in the design of penicillin and cephalosporin antibiotics. J Chem Educ 1976;53:483-8.
22. Hoffmann R, Lipscomb WN. Theory of polyhedral molecules. I. Physical factorizations of the secular equation. J Chem Phys 1962;36:2179-89.
23. Hoffmann, R. An extended Hückel theory. I. Hydrocarbons. J Chem Phys 1963;39:1397-412.
24. Pople JA, Segal GA. Approximate self-consistent molecular orbital theory. II. Calculations with complete neglect of differential overlap. J Chem Phys 1965;43:S136-49.
25. Pople JA, Beveridge DL. Approximate molecular orbital theory. New York:McGraw-Hill, 1970.
26. Hartree, DR. The wave mechanics of an atom with a non-coulomb central field. I. Theory and methods. Proc Cambridge Phil Soc 1928;24:89-110.
27. Hartree, DR. The wave mechanics of an atom with a non-coulomb central field. II. Some results and discussion. Proc Cambridge Phil Soc 1928;24:111-32.
28. Hartree, DR. Wave mechanics of an atom with a non-coulomb central field. III. Term values and intensities in series in optical spectra. Proc Cambridge Phil Soc 1928;24 (Pt. 3):426-37.
29. Fock, V. "Self-consistent field" with interchange for sodium. Zeitschrift für Physik 1930;62:795-805.
30. Roberts JD. Notes on molecular orbital calculations. New York: Benjamin, 1962.
31. Neely WB. The use of molecular orbital calculations as an aid to correlate the structure and activity of cholinesterase inhibitors. Mol Pharmacol 1965;1:137-44.
32. Schnaare RS, Martin AN. Quantum chemistry in drug design. J Pharmaceut Sci 1965;54:1707-13.
33. Parr RG. Quantum theory of molecular electronic structure. New York:Benjamin, 1963.
34. Hammett LP. Physical organic chemistry; reaction rates, equilibria, and mechanisms, 2nd edition. New York: McGraw-Hill, 1970.
35. Taft RW Jr. Linear free-energy relationships from rates of esterification and hydrolysis of aliphatic and ortho-substituted benzoate esters. J Am Chem Soc 1952;74:2729-32.
36. Gould ES. Mechanism and structure in organic chemistry. New York: Holt Reinhart Winston, 1959.
37. Hermann RB. Structure-activity correlations in the cephalosporin C series using extended Hückel theory and CNDO/2. J Antibiot 1973;26:223-7.
38. Boyd DB, Hermann RB, Presti DE, Marsh MM. Electronic structures of cephalosporins and penicillins. 4. Modeling acylation by the beta-lactam ring. J Med Chem 1975;18:408-17.
39. Boyd DB, Herron DK, Lunn WHW, Spitzer WA. Parabolic relationships between antibacterial activity of cephalosporins and beta-lactam reactivity predicted from molecular orbital calculations. J Am Chem Soc 1980;102:1812-14.
40. Boyd DB. Beta-lactam antibacterial agents: Computational chemistry investigations. In: Greenberg A, Breneman CM, Liebman JF, editors. The amide linkage:Structural significance in chemistry, biochemistry, and materials science. New York: Wiley, 2000. p. 337-75.
41. Corey EJ, Wipke WT, Cramer RD III, Howe WJ. Computer-assisted synthetic analysis. Facile man-machine communication of chemical structure by interactive computer graphics. J Am Chem Soc 1972;94:421-30.
42. Corey EJ, Wipke WT, Cramer RD III, Howe WJ. Techniques for perception by a computer of synthetically significant structural features in complex molecules. J Am Chem Soc 1972;94:431-9.
43. Wipke, WT, Gund P. Congestion. Conformation-dependent measure of steric environment. Derivation and application in stereoselective addition to unsaturated carbon. J Am Chem Soc 1974;96:299-301.
44. Bingham RC, Dewar MJS, Lo DH. Ground states of molecules. XXV. MINDO/3. Improved version of the MINDO semiempirical SCF-MO method. J Am Chem Soc 1975;97:1285-93.
45. Löwdin PO, editor. Proceedings of the international symposium on quantum biology and quantum pharmacology, Held at Sanibel Island, Florida, January 17-19, 1974. Int J Quantum Chem, Quantum Biol Symp No. 1. New York: Wiley, 1974.
46. Richards WG. Quantum pharmacology. London, UK: Butterworths, 1977.
47. Olson EC, Christoffersen RE, editors. Computer-assisted drug design, Based on a symposium sponsored by the Divisions of Computers in Chemistry and Medicinal Chemistry at the ACS/CSJ Chemical Congress, Honolulu, Hawaii, April 2-6, 1979. ACS Symposium Series 112. Washington, DC: American Chemical Society, 1979.
48. Allinger NL, Miller MA, Van Catledge FA, Hirsch JA. Conformational analysis. LVII. The calculation of the conformational structures of hydrocarbons by the Westheimer-Hendrickson-Wiberg method. J Am Chem Soc 1967;89:4345-57.
49. Gygax R, Wirz J, Sprague JT, Allinger NL. Electronic structure and photophysical properties of planar conjugated hydrocarbons with a 4n-membered rin. Part III. Conjugative stabilization in an "antiaromatic" system: The conformational mobility of 1,5-bisdehydro[12]annulene. Helv Chim Acta 1977;60:2522-9.
50. Westheimer FH, Mayer JE. The theory of the racemization of optically active derivatives of biphenyl. J Chem Phys 1946;14:733-8.
51. Hendrickson JB. Molecular geometry. I. Machine computation of the common rings. J Am Chem Soc 1961;83:4537-47.
52. Boyd DB, Lipkowitz KB. Molecular mechanics. The method and its underlying philosophy. J Chem Educ 1982;59:269-74.
53. Boyd DB, Lipkowitz KB, editors. Preface on the meaning and scope of computational chemistry. In: Reviews in Computational Chemistry, Vol. 1. New York:VCH, 1990. p. vii-xii.
54. Gund P, Grabowski EJJ, Smith, GM, Andose JD, Rhodes JB, Wipke WT. In:Olson EC, Christoffersen RE, editors. Computer-assisted drug design. ACS Symposium Series 112. Washington, DC: American Chemical Society, 1979. p. 526-51.
55. Allen FH, Bellard S, Brice MD, Cartwright BA, Doubleday A, Higgs H, Hummelink T, Hummelink-Peter BG, Kennard O, Motherwell WDS, Rodgers JR, Watson DG. The Cambridge Crystallographic Data Centre: Computerbased search, retrieval, analysis and display of information. Acta Crystallogr, Sect B 1979; B35:2331-9.
56. Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr., Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. The Protein Data Bank: A computerbased archival file for macromolecular structures. J Mol Biol 1977;112:535-42.
57. Martin YC. Quantitative drug design. A critical introduction. New York: Dekker, 1978.
58. Hansch C, Leo A. Substituent constants for correlation analysis in chemistry and biology. New York: Wiley, 1979.
59. Corey EJ, Long AK, Rubenstein SD. Computer-assisted analysis in organic synthesis. Science 1985;228:408-18.
60. Rubenstein SD. Electronic documents in chemistry, from ChemDraw 1.0 to present. Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, August 22-26, 2004. CINF-054.
61. Helson HE. Structure diagram generation. In: Boyd DB, Lipkowitz KB, editors. Reviews in Computational Chemistry, Vol. 13. New York: Wiley-VCH, 1999. p. 313-98.
62. Monmaney T. Robert Langridge: His quest to peer into the essence of life no longer seems so strange. Smithsonian 2005;36 (8):48.
63. Langridge R. Computer graphics in studies of molecular interactions. Chem Industry (London) 1980 (12):475-7.
64. Langridge R, Ferrin TE, Kuntz ID, Connolly ML. Real-time color graphics in studies of molecular interactions. Science 1981;211 (4483):661-6.
65. Vinter JG. Molecular graphics for the medicinal chemist. Chem Britain 1985;21(1), 32, 33-5, 37-8.
66. Boyd DB. Molecular modeling-Industrial relevance and applications. I: Ullmann's Encyclopedia of Industrial Chemistry, 6th edition. Weinheim, Germany:Wiley-VCH, 1998.
67. Gund P, Andose JD, Rhodes JB, Smith GM. Three-dimensional molecular modeling and drug design. Science 1980;208 (4451):1425-31.
68. Boyd DB, Marsh MM. Computational chemistry in the design of biologically active molecules at Lilly. Abstracts of 183rd National Meeting of the American Chemical Society, Las Vegas, Nevada, March 28-April 2, 1982.
69. Boyd DB. Profile of computer-assisted molecular design in industry. Quantum Chemistry Program Exchange (QCPE) Bulletin 1985;5:85-91.
70. Lipkowitz KB, Boyd DB. Improved job market for computational chemists. In:Reviews in Computational Chemistry, Vol. 12. New York: Wiley-VCH, 1998. p. v-xiii.
71. Marshall GR, Barry CD, Bosshard HE, Dammkoehler RA, Dunn DA. The conformational parameter in drug design: The active analog approach. Computer-assisted drug design. ACS Symposium Series 112. Washington DC:American Chemical Society, 1979. p. 205-26.
72. Martin YC, Bures MG, Willett P. Searching databases of three-dimensional structures. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 1. New York: VCH, 1990. p. 213-63.
73. Grethe G, Moock TE. Similarity searching in REACCS. A new tool for the synthetic chemist. J Chem Inf Comput Sci 1990;30:511-20.
74. Dewar MJS, Healy EF, Stewart JJP. Location of transition states in reaction mechanism. J Chem Soc, Faraday Transactions 2: Mol Chem Phys 1984;80:227-33.
75. Stewart JJP. MOPAC: A semiempirical molecular orbital program. J Computer-Aided Mol Des 1990;4:1-105.
76. Stewart JJP. Semiempirical molecular orbital methods. In: Lipkowitz KB, Boyd DB, editors, Reviews in Computational Chemistry, Vol. 1. New York: VCH, 1990. p. 45-81.
77. Stewart JJP. MOPAC: A semiempirical molecular orbital program. Quantum Chemistry Program Exchange, 1983. Prog.455.
78. Allinger NL. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem Soc 1977;99:8127-34.
79. Burkert U, Allinger NL. Molecular mechanics. ACS Monograph 177. Washington DC: American Chemical Society, 1982.
80. Leo AJ. Some advantages of calculating octanol-water partition coefficients. J Pharmaceut Sci 1987;76:166-8.
81. Leo AJ. Hydrophobic parameter: measurement and calculation. Methods Enzymol 1991;202:544-91.
82. Leo, AJ. Calculating log Poct from structures. Chem Rev 1993;93:1281-306.
83. Enslein, Kurt. Estimation of toxicological endpoints by structure-activity relationships. Pharmacol Rev 1984;36 (2, Suppl.):131-5.
84. Enslein, K. An overview of structure-activity relationships as an alternative to testing in animals for carcinogenicity, mutagenicity, dermal and eye irritation, and acute oral toxicity. Toxicol Industrial Health 1988;4:479-98.
85. Boyd DB. Application of the hypersurface iterative projection method to bicyclic pyrazolidinone antibacterial agents. J Med Chem 1993;36:1443-9.
86. Matthews DA, Alden RA, Bolin JT, Filman DJ, Freer ST, Hamlin R, Hol WG, Kisliuk RL, Pastore EJ, Plante LT, Xuong N, Kraut J. Dihydrofolate reductase from Lactobacillus casei. X-ray structure of the enzyme methotrexate-NADPH complex. J Biol Chem 1978;253:6946-54.
87. Matthews DA, Alden RA, Freer ST, Nguyen HX, Kraut J. Dihydrofolate reductase from Lactobacillus casei. Stereochemistry of NADPH binding. J Biol Chem 1979;254:4144-51.
88. Everett AJ. Computing and trial and error in chemotherapeutic research. In:Leeming PR, editor. Topics in Medicinal Chemistry, Proceedings of the 4th SCIRSC Medicinal Chemistry Symposium, Cambridge, UK, Sept. 6-9, 1987. Special Publication 65. London: Royal Society of Chemistry, 1988. p. 314-31.
89. Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, Mitsuhashi S. In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother 1980;17:103-8.
90. Koga H, Itoh A, Murayama S, Suzue S, Irikura T. Structure-activity relationships of antibacterial 6,7-and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. J Med Chem 1980;23;1358-63.
91. Koga H. Structure-activity relationships and drug design of pyridonecarboxylic acid type (nalidixic acid type) synthetic antibacterial agents. Kagaku no Ryoiki, Zokan 1982;136:177-202.
92. Perun TJ, Propst CL, editors. Computer-aided drug design: Methods and applications. New York: Dekker, 1989.
93. Brünger A, Karplus M, Petsko GA. Crystallographic refinement by simulated annealing: application to crambin. Acta Crystallogr, Sect A 1989; A45:50-61.
94. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983;4:187-217.
95. Kollman, P. Molecular modeling. Annu Rev Phys Chem 1987;38:303-16.
96. McCammon, JA. Computer-aided molecular design. Science 1987;238(4826):486-91.
97. Reddy MR, Erion MD, Agarwal A. Free energy calculations: Use and limitations in predicting ligand binding affinities. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 16. New York: Wiley-VCH, 2000. p. 217-304.
98. Karin S, Smith NP. The supercomputer era. Boston: Harcourt Brace Jovanovich, 1987.
99. Wold JS. Supercomputing network: A key to U.S. competitiveness in industries based on life-sciences excellence. Testimony before the U.S. Senate, Commerce, Science and Transportation Committee Science, Technology and Space Subcommittee. http://www.funet.fi/pub/sci/molbio/historical/biodocs/wold.txt
100. Milosevich SAF, Boyd, DB. Supercomputing and drug discovery research. Perspect Drug Discovery Design 1993;1:345-58.
101. Richon AB. A history of computational chemistry. http://www.netsci.org/Science/Compchem/feature17a.html.
102. Halgren TA. The representation of van der Waals (vdW) interactions in molecular mechanics force fields: Potential form, combination rules, and vdW parameters. J Am Chem Soc 1992;114:7827-43.
103. Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization and performance of MMFF94. J Comput Chem 1996;17:490-519.
104. Halgren TA. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J Comput Chem 1996;17:520-52.
105. Halgren, T. A. Merck Molecular Force Field. III. Molecular geometrics and vibrational frequencies for MMFF94. J Comput Chem 1996, 17:553-86.
106. Halgren TA, Nachbar RB. Merck molecular force field. IV. Conformational energies and geometries. J Comput Chem 1996;17:587-615.
107. Halgren TA. Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data and empirical rules. J Comput Chem 1996;17:616-41.
108. Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999;20:720-29.
109. Boyd DB, Lipkowitz KB, History of the Gordon Research Conferences on Computational Chemistry. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 14. New York: Wiley-VCH, 2000. p. 399-439.
110. Mohamadi F, Richards NGJ, Guida WC, Liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC. MacroModel-An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 1990;11:440-67.
111. Sprague PW. Catalyst: A computer aided drug design system specifically designed for medicinal chemists. Recent Advances in Chemical Information, Special Publication 100, Royal Society of Chemistry, 1992. p. 107-11.
112. Blaney JM, Dixon JS. A good ligand is hard to find: Automated docking methods. Perspect Drug Discovery Design 1993;1:301-19.
113. Boehm H-J. Fragment-based de novo ligand design. Proceedings of the Alfred Benzon Symposium No. 39, 1996. p. 402-13.
114. Murcko MA. Recent advances in ligand design methods. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 11. New York:Wiley-VCH, 1997. p. 1-66.
115. Clark DE, Murray CW, Li J. Current issues in de novo molecular design. In:Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 11. New York: Wiley-VCH, 1997. p. 67-125.
116. Lauri G, Bartlett PA. CAVEAT: A program to facilitate the design of organic molecules. J Comput-Aided Mol Des 1994;8:51-66.
117. Walters WP, Stahl MT, Murcko MA. Virtual screening-An overview. Drug Discovery Today 1998;3:160-78.
118. Lewis RA, Pickett SD, Clark DE. Computer-aided molecular diversity analysis and combinatorial library design. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 16. New York: Wiley, 2000. p. 1-51.
119. Boyd DB, Lipkowitz KB, editors. Trends in the job market for computational chemists. Reviews in Computational Chemistry, Vol. 7. New York: VCH, 1996. p. v-xi.
120. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25.
121. Hansch C, Leo A, Hoekman D. Exploring QSAR: Hydrophobic, electronic, and steric constants. Washington DC: American Chemical Society, 1995.
122. Todeschini R, Consonni V. Handbook of molecular descriptors. Berlin: Wiley-VCH, 2000.
123. Karelson M. Molecular descriptors in QSAR/QSPR. New York: Wiley, 2000.
124. Boyd DB. Progress in rational design of therapeutically interesting compounds. In: Liljefors T, Jørgensen FS, Krogsgaard-Larsen P, editors. Rational molecular design in drug research. Proceedings of the Alfred Benzon Symposium No. 42. Copenhagen: Munksgaard, 1998. p. 15-23.
125. Boyd DB. Innovation and the rational design of drugs. CHEMTECH 1998;28 (5):19-23.
126. Boyd DB. Rational drug design: Controlling the size of the haystack. Modern Drug Discovery, November/December 1998. p. 41-8.
127. Boyd DB. Drug design. In: Schleyer PvR, Allinger NL, Clark T, Gasteiger J, Kollman P, Schaefer HF III, editors. Encyclopedia of computational chemistry, Vol. 1. Chichester: Wiley, 1998. p. 795-804.
128. Boyd DB. Is rational design good for anything? In: Parrill AL, Reddy MR, editors, Rational drug design: Novel methodology and practical applications. ACS Symp Series 719. Washington, DC: American Chemical Society, 1999. p. 346-56.
129. Zurer P. Crixivan. Chem Eng News, June 20, 2005. p.54.
130. Dyason JC, Wilson JC, Von Itzstein M. Sialidases: Targets for rational drug design. In: Bultinck P, De Winter H, Langenaeker W, Tollenaere JP, editors, Computational medicinal chemistry for drug discovery. New York: Dekker, 2004.
131. Walters DE, Hopfinger AJ. Case studies of the application of molecular shape analysis to elucidate drug action. THEOCHEM 1986 27:317-23.
132. DePriest SA, Mayer D, Naylor CB, Marshall GR. 3D-QSAR of angiotensinconverting enzyme and thermolysin inhibitors: a comparison of CoMFA models based on deduced and experimentally determined active site geometries. J Am Chem Soc 1993;115:5372-84.
133. Congreve M, Murray CW, Blundell TL. Structural biology and drug discovery. Drug Discovery Today 2005;10:895-907.
134. Boyd DB, Palkowitz AD, Thrasher KJ, Hauser KL, Whitesitt CA, Reel JK, Simon RL, Pfeifer W, Lifer SL, Takeuchi K, Vasudevan V, Kossoy AD, Deeter JB, Steinberg MI, Zimmerman KM, Wiest SA, Marshall WS. Molecular modeling and quantitative structure-activity relationship studies in pursuit of highly potent substituted octanoamide angiotensin II receptor antagonists. In:Reynolds CH, Holloway MK, Cox HK, editors. Computer-aided molecular design: Applications in agrochemicals, materials, and pharmaceuticals, ACS Symp. Series 589, Washington, DC: American Chemical Society, 1995. p. 14-35.
135. Boyd DB, Lipkowitz KB. Examination of the employment environment for computational chemistry. In: Lipkowitz KB, Boyd DB, editors. Reviews in Computational Chemistry, Vol. 18. New York: Wiley-VCH, 2002. p. 293-319.
136. Schmid EF, Smith DA. Is declining innovation in the pharmaceutical industry a myth? Drug Discovery Today 2005;10:1031-9.